Methadone dosing in patients on ritonavir-boosted-based highly active antiretroviral therapy

Med Clin (Barc). 2019 Feb 15;152(4):161-162. doi: 10.1016/j.medcli.2018.03.004. Epub 2018 Apr 21.

[Article in English, Spanish]

Authors

Roberto Lozano¹, Nieves Domeque², Alberto Jose Frutos³

Affiliations

¹ Servicio de Farmacia, Hospital Real de Nuestra Señora de Gracia, Zaragoza, Spain. Electronic address: rlozano@salud.aragon.es.
² Servicio Psiquiatría, Hospital Real de Nuestra Señora de Gracia, Zaragoza, Spain.
³ Servicio Farmacia, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.

PMID: 29685312
DOI: 10.1016/j.medcli.2018.03.004

No abstract available

Publication types

Observational Study

MeSH terms

Anti-HIV Agents / therapeutic use
Antiretroviral Therapy, Highly Active*
Cytochrome P-450 CYP3A Inhibitors / metabolism
Cytochrome P-450 CYP3A Inhibitors / therapeutic use
Drug Dosage Calculations
Drug Interactions
Female
HIV Infections / drug therapy
HIV Infections / metabolism
HIV Protease Inhibitors / metabolism
HIV Protease Inhibitors / therapeutic use*
Humans
Male
Methadone / administration & dosage*
Methadone / metabolism
Middle Aged
Narcotics / administration & dosage*
Narcotics / metabolism
Opiate Substitution Treatment
Retrospective Studies
Ritonavir / metabolism
Ritonavir / therapeutic use*

Substances

Anti-HIV Agents
Cytochrome P-450 CYP3A Inhibitors
HIV Protease Inhibitors
Narcotics
Ritonavir
Methadone